Funding Foster Collaboration with Norner for Advancement of Sutrips
MUB Medical Solutions, a pioneering medical technology company, is thrilled to announce that it has secured funding from Norsk Katapult, a leading organization supporting innovation and technology development in Norway. This funding will facilitate a close collaboration between MUB Medical and Norner, a renowned industrial polymer Research & Development center with extensive expertise in the polymer and plastics industry.
Norner, boasting over 40 years of experience, stands as a prominent hub for cutting-edge polymer research and development. With a diverse team of 92 employees representing 16 nationalities, Norner is at the forefront of exciting advancements in the field. The collaboration between MUB Medical and Norner represents a significant opportunity to leverage Norner’s wealth of knowledge and resources in the pursuit of furthering the development of Sutrips.
The primary objective of this collaboration is to validate and optimize the design of Sutrips, ensuring its compatibility with medical-grade materials and refining the production methodology. Norner’s deep understanding of polymer science and their proficiency in conducting rigorous testing will be instrumental in assessing the performance, durability, and safety aspects of Sutrips. The ultimate aim is to enhance the functionality and reliability of Sutrips, paving the way for its successful implementation in clinical settings.
The funding provided by Norsk Katapult serves as a testament to MUB Medical’s innovative approach and reinforces the importance of fostering collaborations between industry leaders. This support not only validates the potential of Sutrips but also underscores the significance of advancing medical technology solutions to address critical healthcare challenges.
MUB Medical is excited to embark on this collaborative journey with Norner and is confident that this partnership will yield valuable insights and advancements in the development of Sutrips. By combining Norner’s extensive expertise with MUB Medical’s dedication to innovation and patient-centric design, the collaboration aims to accelerate the progress of Sutrips, ensuring its readiness for market entry.
As the collaboration with Norner unfolds, MUB Medical remains committed to its mission of revolutionizing wound closure and improving patient outcomes. The company believes that by working closely with industry leaders and research institutions, it can foster innovation, drive advancements, and positively impact healthcare practices.